VMGMX
Price
$132.08
Change
+$0.31 (+0.24%)
Updated
Jun 22 closing price
Net Assets
33.76B
WMGRX
Price
$21.64
Change
-$0.16 (-0.73%)
Updated
Jun 22 closing price
Net Assets
2.96B
Interact to see
Advertisement

VMGMX vs WMGRX

VMGMX vs WMGRX Comparison Chart in %
View a ticker or compare two or three
VS
VMGMX vs. WMGRX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VMGMX is a StrongBuy and WMGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMGMX has more cash in the bank: 33.8B vs. WMGRX (2.96B). VMGMX pays higher dividends than WMGRX: VMGMX (0.62) vs WMGRX (0.00). VMGMX was incepted earlier than WMGRX: VMGMX (15 years) vs WMGRX (20 years). WMGRX (1.45) is less costly to investors than VMGMX (0.07). WMGRX is a more actively managed with annual turnover of: 42.00 vs. VMGMX (17.00). WMGRX has a lower initial minimum investment than VMGMX: WMGRX (0) vs VMGMX (3000). VMGMX annual gain was more profitable for investors over the last year : 12.44 vs. WMGRX (-4.76). VMGMX return over 5 years is better than : 31.82 vs. WMGRX (-43.68).
VMGMXWMGRXVMGMX / WMGRX
Total Expense Ratio0.071.295%
Annual Report Gross Expense Ratio0.071.455%
Fund Existence15 years20 years-
Gain YTD9.6943.416284%
Front LoadN/AN/A-
Min. Initial Investment30000-
Min. Initial Investment IRAN/AN/A-
Net Assets33.8B2.96B1,143%
Annual Yield % from dividends0.620.00-
Returns for 1 year12.44-4.76-261%
Returns for 3 years55.17-13.32-414%
Returns for 5 years31.82-43.68-73%
Returns for 10 years212.4016.271,306%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TEMUX22.47N/A
N/A
Morgan Stanley Pathway Em Mkts Eq
MRICX26.84N/A
N/A
MFS Research International C
ICSSX16.85N/A
N/A
VY® Columbia Small Cp Val & InflectionS
ALVDX11.11N/A
N/A
American Century Focused Lg Cap Val R6
BRUMX18.25N/A
N/A
MFS Blended Research Value Equity R4